HC Wainwright Research Analysts Decrease Earnings Estimates for Legend Biotech Co. (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Investment analysts at HC Wainwright decreased their Q4 2025 earnings per share (EPS) estimates for Legend Biotech in a report released on Friday, May 24th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of $0.10 for the quarter, down from […]

Related Keywords

United States ,Canada ,Texas ,China ,American ,Raymond James ,Vanguard Personalized Indexing Management ,Scotiabank ,Avior Wealth Management ,Nasdaq ,Us Bancorp ,American International Group Inc ,Legend Biotech Co ,Legend Biotech Company Profile ,Legend Biotech Corporation ,Cantor Fitzgerald ,Royal Bank ,Legend Biotech ,Free Report ,Get Free Report ,Wealth Management ,Personalized Indexing Management ,Retirement System ,American International Group ,International Group ,Biotech Corporation ,Legend Biotech Daily ,